Yahoo Finance

Orion Corporation and Menarini Group collaborate on budesonide-formoterol Easyhaler® combination product for asthma and COPD

Press release 2 September 2016 at 1.00 p.m. EEST Orion Corporation announced today that it has entered into a collaboration agreement with Menarini Group, for the co-marketing of budesonide-formoterol ...
Medscape

Closer to an 'Ideal Inhaler' With the Easyhaler

In conclusion, the Easyhaler ® more closely demonstrates the characteristics of an ‘ideal inhaler' than its competitors (consistent fine particle dose, performance regardless of inspiration rate, ...
Yahoo Finance

Orion receives first marketing authorisations for Bufomix Easyhaler® product

Orion Corporation has received Irish and Hungarian marketing authorisation for Bufomix Easyhaler®, an inhaled budesonide-formoterol combination product indicated for asthma and chronic obstructive ...
Yahoo Finance

Pediapharm Inc. Receives Health Canada Notice of Deficiency-Withdrawal Letter for Easyhaler Budesonide, and Will File a Request for Reconsideration

Pediapharm Inc. (TSX VENTURE:PDP) ("Pediapharm" or the "Company") announced today that it has received a Notice of Deficiency - Withdrawal Letter from Health Canada regarding its New Drug Submission ...
Yahoo Finance

Health Canada Upholds Notice of Deficiency-Withdrawal Letter Regarding Easyhaler Budesonide

Pediapharm Inc. ("Pediapharm" or the "Company") (TSX VENTURE:PDP) announces that Health Canada has upheld the May 2015 Notice of Deficiency - Withdrawal Letter regarding Easyhaler Budesonide, without ...
Finanznachrichten

Orion Oyj: Orion has submitted a marketing authorisation application for combined budesonide-formoterol formulation of the Easyhaler product family

ORION CORPORATION STOCK EXCHANGE RELEASE 21 MARCH 2013 at 6.25 p.m. EET Orion Corporation has submitted a marketing authorisation application for combined budesonide-formoterol formulation of the ...
clinicaladvisor.com

Asthma Inhalers: Salbutamol Easyhaler as Effective as Ventolin Evohaler

In both the Easyhaler DPI and Evohaler pMDI cohorts, 98.3% of patients with asthma recovered FEV1 to at least -10% of baseline after their last treatment post MC test. Investigators sought to ...
Yahoo Finance

Orion Corporation and Menarini Group collaborate on budesonide-formoterol Easyhaler® combination product for asthma and COPD

a strong partner focusing on respiratory therapy area. The collaboration accelerates the good momentum we have for Easyhaler products in Europe and strengthens Orion`s strategic objective to become a ...
Medscape

Closer to an 'Ideal Inhaler' With the Easyhaler

Clin Drug Invest. 2005;26(4):175-183.
Yahoo Finance

Orion receives first marketing authorisations for Bufomix Easyhaler® product

ORION CORPORATION STOCK EXCHANGE RELEASE 14 APRIL 2014 at 9:30 PM EEST Orion receives first marketing authorisations for Bufomix Easyhaler® product Orion Corporation has received Irish and Hungarian ...
Finanznachrichten

Orion Oyj: Orion Corporation and Menarini Group collaborate on budesonide-formoterol Easyhaler combination product for asthma and COPD

Press release 2 September 2016 at 1.00 p.m. EEST Orion Corporation announced today that it has entered into a collaboration agreement with Menarini Group, for the co-marketing of budesonide-formoterol ...